Hutchin Hill Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$204K Sell
4,600
-26,600
-85% -$1.21M 0.06% 343
2017
Q3
$1.56M Buy
31,200
+24,200
+346% +$1.24M 0.06% 255
2017
Q2
$370K Buy
7,000
+100
+1% +$5.36K 0.01% 720
2017
Q1
$383K Sell
6,900
-20,353
-75% -$1.12M 0.01% 759
2016
Q4
$1.42M Sell
27,253
-5,547
-17% -$268K 0.05% 404
2016
Q3
$1.58M Buy
+32,800
New +$1.66M 0.03% 286
2016
Q1
Sell
-54,200
Closed -$2.79M 743
2015
Q4
$2.79M Buy
+54,200
New +$2.69M 0.07% 251
2015
Q3
Sell
-69,900
Closed -$3.23M 716
2015
Q2
$3.23M Buy
69,900
+28,584
+69% +$1.25M 0.08% 220
2015
Q1
$1.77M Buy
+41,316
New +$1.57M 0.05% 329
2014
Q3
Sell
-7,500
Closed -$254K 688
2014
Q2
$254K Buy
+7,500
New +$240K 0.01% 546
2013
Q3
Sell
-9,100
Closed -$265K 554
2013
Q2
$265K Buy
+9,100
New +$257K 0.03% 349

Other funds holding PBH

Hutchin Hill Capital's PBH Position: Q4 2017 in Review

Hutchin Hill Capital reduced its Prestige Consumer Healthcare (PBH) stake by 85% in Q4 2017, selling an estimated $1.21M and leaving 4,600 shares worth $204K. The position accounts for 0.06% of the portfolio, ranked #343.

Hutchin Hill Capital first reported a position in PBH in Q2 2013 and has held it in 11 quarters since. The position peaked at $3.23M in Q2 2015. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

  • Hutchin Hill Capital held 4,600 shares of Prestige Consumer Healthcare worth $204K as of Q4 2017.
  • Hutchin Hill Capital sold 26,600 Prestige Consumer Healthcare shares in Q4 2017, an estimated $1.21M.
  • Prestige Consumer Healthcare made up 0.06% of Hutchin Hill Capital's portfolio in Q4 2017, its #343 holding.
  • Hutchin Hill Capital first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 11 quarters since.
  • Hutchin Hill Capital's Prestige Consumer Healthcare position peaked at $3.23M in Q2 2015.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.